Global and United States Hemophilia Treatment Market Report & Forecast 2023-2028

Report ID: 1842775 | Published Date: Jan 2025 | No. of Page: 86 | Base Year: 2024 | Rating: 4 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Study Coverage
    1.1 Hemophilia Treatment Revenue in Hemophilia Treatment Business (2017-2022) & (US$ Million) Introduction
    1.2 Global Hemophilia Treatment Outlook 2017 VS 2022 VS 2028
        1.2.1 Global Hemophilia Treatment Market Size for the Year 2017-2028
        1.2.2 Global Hemophilia Treatment Market Size for the Year 2017-2028
    1.3 Hemophilia Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
        1.3.1 The Market Share of United States Hemophilia Treatment in Global, 2017 VS 2022 VS 2028
        1.3.2 The Growth Rate of Hemophilia Treatment Market Size, United States VS Global, 2017 VS 2022 VS 2028
    1.4 Hemophilia Treatment Market Dynamics
        1.4.1 Hemophilia Treatment Industry Trends
        1.4.2 Hemophilia Treatment Market Drivers
        1.4.3 Hemophilia Treatment Market Challenges
        1.4.4 Hemophilia Treatment Market Restraints
    1.5 Study Objectives
    1.6 Years Considered
2 Hemophilia Treatment by Type
    2.1 Hemophilia Treatment Market Segment by Type
        2.1.1 On-demand
        2.1.2 Prophylaxis
    2.2 Global Hemophilia Treatment Market Size by Type (2017, 2022 & 2028)
    2.3 Global Hemophilia Treatment Market Size by Type (2017-2028)
    2.4 United States Hemophilia Treatment Market Size by Type (2017, 2022 & 2028)
    2.5 United States Hemophilia Treatment Market Size by Type (2017-2028)
3 Hemophilia Treatment by Application
    3.1 Hemophilia Treatment Market Segment by Application
        3.1.1 Replacement Therapy
        3.1.2 ITI Therapy
        3.1.3 Gene Therapy
    3.2 Global Hemophilia Treatment Market Size by Application (2017, 2022 & 2028)
    3.3 Global Hemophilia Treatment Market Size by Application (2017-2028)
    3.4 United States Hemophilia Treatment Market Size by Application (2017, 2022 & 2028)
    3.5 United States Hemophilia Treatment Market Size by Application (2017-2028)
4 Global Hemophilia Treatment Competitor Landscape by Company
    4.1 Global Hemophilia Treatment Market Size by Company
        4.1.1 Top Global Hemophilia Treatment Companies Ranked by Revenue (2021)
        4.1.2 Global Hemophilia Treatment Revenue by Player (2017-2022)
    4.2 Global Hemophilia Treatment Concentration Ratio (CR)
        4.2.1 Hemophilia Treatment Market Concentration Ratio (CR) (2017-2022)
        4.2.2 Global Top 5 and Top 10 Largest Companies of Hemophilia Treatment in 2021
        4.2.3 Global Hemophilia Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    4.3 Global Hemophilia Treatment Headquarters, Revenue in Hemophilia Treatment Business (2017-2022) & (US$ Million) Type
        4.3.1 Global Hemophilia Treatment Headquarters and Area Served
        4.3.2 Global Hemophilia Treatment Companies Revenue in Hemophilia Treatment Business (2017-2022) & (US$ Million) Type
        4.3.3 Date of International Companies Enter into Hemophilia Treatment Market
    4.4 Companies Mergers & Acquisitions, Expansion Plans
    4.5 United States Hemophilia Treatment Market Size by Company
        4.5.1 Top Hemophilia Treatment Players in United States, Ranked by Revenue (2021)
        4.5.2 United States Hemophilia Treatment Revenue by Players (2020, 2021 & 2022)
5 Global Hemophilia Treatment Market Size by Region
    5.1 Global Hemophilia Treatment Market Size by Region: 2017 VS 2022 VS 2028
    5.2 Global Hemophilia Treatment Market Size by Region (2017-2028)
        5.2.1 Global Hemophilia Treatment Market Size by Region: 2017-2022
        5.2.2 Global Hemophilia Treatment Market Size by Region (2023-2028)
6 Segment in Region Level & Country Level
    6.1 North America
        6.1.1 North America Hemophilia Treatment Market Size YoY Growth 2017-2028
        6.1.2 North America Hemophilia Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.1.3 U.S.
        6.1.4 Canada
    6.2 Asia-Pacific
        6.2.1 Asia-Pacific Hemophilia Treatment Market Size YoY Growth 2017-2028
        6.2.2 Asia-Pacific Hemophilia Treatment Market Facts & Figures by Region (2017, 2022 & 2028)
        6.2.3 China
        6.2.4 Japan
        6.2.5 South Korea
        6.2.6 India
        6.2.7 Australia
        6.2.8 Taiwan
        6.2.9 Indonesia
        6.2.10 Thailand
        6.2.11 Malaysia
        6.2.12 Philippines
    6.3 Europe
        6.3.1 Europe Hemophilia Treatment Market Size YoY Growth 2017-2028
        6.3.2 Europe Hemophilia Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.3.3 Germany
        6.3.4 France
        6.3.5 U.K.
        6.3.6 Italy
        6.3.7 Russia
    6.4 Latin America
        6.4.1 Latin America Hemophilia Treatment Market Size YoY Growth 2017-2028
        6.4.2 Latin America Hemophilia Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.4.3 Mexico
        6.4.4 Brazil
        6.4.5 Argentina
    6.5 Middle East and Africa
        6.5.1 Middle East and Africa Hemophilia Treatment Market Size YoY Growth 2017-2028
        6.5.2 Middle East and Africa Hemophilia Treatment Market Facts & Figures by Country (2017, 2022 & 2028)
        6.5.3 Turkey
        6.5.4 Saudi Arabia
        6.5.5 U.A.E
7 Company Profiles
    7.1 CSL Behring
        7.1.1 CSL Behring Company Details
        7.1.2 CSL Behring Business Overview
        7.1.3 CSL Behring Hemophilia Treatment Introduction
        7.1.4 CSL Behring Revenue in Hemophilia Treatment Business (2017-2022)
        7.1.5 CSL Behring Recent Development
    7.2 Baxalta
        7.2.1 Baxalta Company Details
        7.2.2 Baxalta Business Overview
        7.2.3 Baxalta Hemophilia Treatment Introduction
        7.2.4 Baxalta Revenue in Hemophilia Treatment Business (2017-2022)
        7.2.5 Baxalta Recent Development
    7.3 Pfizer Inc
        7.3.1 Pfizer Inc Company Details
        7.3.2 Pfizer Inc Business Overview
        7.3.3 Pfizer Inc Hemophilia Treatment Introduction
        7.3.4 Pfizer Inc Revenue in Hemophilia Treatment Business (2017-2022)
        7.3.5 Pfizer Inc Recent Development
    7.4 BioMarin
        7.4.1 BioMarin Company Details
        7.4.2 BioMarin Business Overview
        7.4.3 BioMarin Hemophilia Treatment Introduction
        7.4.4 BioMarin Revenue in Hemophilia Treatment Business (2017-2022)
        7.4.5 BioMarin Recent Development
    7.5 Bayer Healthcare
        7.5.1 Bayer Healthcare Company Details
        7.5.2 Bayer Healthcare Business Overview
        7.5.3 Bayer Healthcare Hemophilia Treatment Introduction
        7.5.4 Bayer Healthcare Revenue in Hemophilia Treatment Business (2017-2022)
        7.5.5 Bayer Healthcare Recent Development
    7.6 Biogen
        7.6.1 Biogen Company Details
        7.6.2 Biogen Business Overview
        7.6.3 Biogen Hemophilia Treatment Introduction
        7.6.4 Biogen Revenue in Hemophilia Treatment Business (2017-2022)
        7.6.5 Biogen Recent Development
    7.7 Novo Nordisk
        7.7.1 Novo Nordisk Company Details
        7.7.2 Novo Nordisk Business Overview
        7.7.3 Novo Nordisk Hemophilia Treatment Introduction
        7.7.4 Novo Nordisk Revenue in Hemophilia Treatment Business (2017-2022)
        7.7.5 Novo Nordisk Recent Development
    7.8 Roche
        7.8.1 Roche Company Details
        7.8.2 Roche Business Overview
        7.8.3 Roche Hemophilia Treatment Introduction
        7.8.4 Roche Revenue in Hemophilia Treatment Business (2017-2022)
        7.8.5 Roche Recent Development
    7.9 Takeda
        7.9.1 Takeda Company Details
        7.9.2 Takeda Business Overview
        7.9.3 Takeda Hemophilia Treatment Introduction
        7.9.4 Takeda Revenue in Hemophilia Treatment Business (2017-2022)
        7.9.5 Takeda Recent Development
8 Research Findings and Conclusion
9 Appendix
    9.1 Research Methodology
        9.1.1 Methodology/Research Approach
        9.1.2 Data Source
    9.2 Author Details
    9.3 Disclaimer

List of Tables
    Table 1. Hemophilia Treatment Market Size United States VS Global, CAGR (2017 VS 2022 VS 2028)
    Table 2. Hemophilia Treatment Market Trends
    Table 3. Hemophilia Treatment Market Drivers
    Table 4. Hemophilia Treatment Market Challenges
    Table 5. Hemophilia Treatment Market Restraints
    Table 6. Global Hemophilia Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 7. United States Hemophilia Treatment Market Size by Type: 2017 VS 2022 VS 2028 (US$ Million)
    Table 8. Global Hemophilia Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 9. United States Hemophilia Treatment Market Size by Application: 2017 VS 2022 VS 2028 (US$ Million)
    Table 10. Top Hemophilia Treatment Companies in Global Market, Ranking by Revenue (2021)
    Table 11. Global Hemophilia Treatment Revenue by Player, (US$ Million), 2017-2022
    Table 12. Global Hemophilia Treatment Revenue Share by Player, 2017-2022
    Table 13. Global Hemophilia Treatment Companies Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Hemophilia Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hemophilia Treatment as of 2021)
    Table 15. Top Players of Hemophilia Treatment in Global Market, Headquarters and Area Served
    Table 16. Companies Revenue in Hemophilia Treatment Business (2017-2022) & (US$ Million) Type
    Table 17. Date of International Companies Enter into Hemophilia Treatment Market
    Table 18. Companies Mergers & Acquisitions, Expansion Plans
    Table 19. Top Hemophilia Treatment Players in United States Market, Ranking by Revenue (2021)
    Table 20. United States Hemophilia Treatment Revenue by Players, (US$ Million), 2020, 2021 & 2022
    Table 21. United States Hemophilia Treatment Revenue Share by Players, 2020, 2021 & 2022
    Table 22. Global Hemophilia Treatment Market Size by Region (US$ Million): 2017 VS 2022 VS 2028
    Table 23. Global Hemophilia Treatment Market Size by Region (2017-2022) & (US$ Million)
    Table 24. Global Hemophilia Treatment Market Size Forecast by Region (2023-2028) & (US$ Million)
    Table 25. North America Hemophilia Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 26. Asia Pacific Hemophilia Treatment Sales in Value by Region (2017-2028) & (US$ Million)
    Table 27. Europe Hemophilia Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 28. Latin Americaa Hemophilia Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 29. Middle East and Africa Hemophilia Treatment Sales in Value by Country (2017-2028) & (US$ Million)
    Table 30. CSL Behring Company Details
    Table 31. CSL Behring Business Overview
    Table 32. CSL Behring Hemophilia Treatment Product
    Table 33. CSL Behring Revenue in Hemophilia Treatment Business (2017-2022) & (US$ Million)
    Table 34. CSL Behring Recent Development
    Table 35. Baxalta Company Details
    Table 36. Baxalta Business Overview
    Table 37. Baxalta Hemophilia Treatment Product
    Table 38. Baxalta Revenue in Hemophilia Treatment Business (2017-2022) & (US$ Million)
    Table 39. Baxalta Recent Development
    Table 40. Pfizer Inc Company Details
    Table 41. Pfizer Inc Business Overview
    Table 42. Pfizer Inc Hemophilia Treatment Product
    Table 43. Pfizer Inc Revenue in Hemophilia Treatment Business (2017-2022) & (US$ Million)
    Table 44. Pfizer Inc Recent Development
    Table 45. BioMarin Company Details
    Table 46. BioMarin Business Overview
    Table 47. BioMarin Hemophilia Treatment Product
    Table 48. BioMarin Revenue in Hemophilia Treatment Business (2017-2022) & (US$ Million)
    Table 49. BioMarin Recent Development
    Table 50. Bayer Healthcare Company Details
    Table 51. Bayer Healthcare Business Overview
    Table 52. Bayer Healthcare Hemophilia Treatment Product
    Table 53. Bayer Healthcare Revenue in Hemophilia Treatment Business (2017-2022) & (US$ Million)
    Table 54. Bayer Healthcare Recent Development
    Table 55. Biogen Company Details
    Table 56. Biogen Business Overview
    Table 57. Biogen Hemophilia Treatment Product
    Table 58. Biogen Revenue in Hemophilia Treatment Business (2017-2022) & (US$ Million)
    Table 59. Biogen Recent Development
    Table 60. Novo Nordisk Company Details
    Table 61. Novo Nordisk Business Overview
    Table 62. Novo Nordisk Hemophilia Treatment Product
    Table 63. Novo Nordisk Revenue in Hemophilia Treatment Business (2017-2022) & (US$ Million)
    Table 64. Novo Nordisk Recent Development
    Table 65. Roche Company Details
    Table 66. Roche Business Overview
    Table 67. Roche Hemophilia Treatment Product
    Table 68. Roche Revenue in Hemophilia Treatment Business (2017-2022) & (US$ Million)
    Table 69. Roche Recent Development
    Table 70. Takeda Company Details
    Table 71. Takeda Business Overview
    Table 72. Takeda Hemophilia Treatment Product
    Table 73. Takeda Revenue in Hemophilia Treatment Business (2017-2022) & (US$ Million)
    Table 74. Takeda Recent Development
    Table 75. Research Programs/Design for This Report
    Table 76. Key Data Information from Secondary Sources
    Table 77. Key Data Information from Primary Sources
List of Figures
    Figure 1. Hemophilia Treatment Product Picture
    Figure 2. Global Hemophilia Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 3. Global Hemophilia Treatment Market Size 2017-2028 (US$ Million)
    Figure 4. United States Hemophilia Treatment Market Size, (US$ Million), 2017 VS 2022 VS 2028
    Figure 5. United States Hemophilia Treatment Market Size 2017-2028 (US$ Million)
    Figure 6. United States Hemophilia Treatment Market Share in Global 2017-2028
    Figure 7. Hemophilia Treatment Report Years Considered
    Figure 8. Product Picture of On-demand
    Figure 9. Product Picture of Prophylaxis
    Figure 10. Global Hemophilia Treatment Market Share by Type in 2022 & 2028
    Figure 11. Global Hemophilia Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 12. Global Hemophilia Treatment Market Share by Type (2017-2028)
    Figure 13. United States Hemophilia Treatment Market Share by Type in 2022 & 2028
    Figure 14. United States Hemophilia Treatment Market Size by Type (2017-2028) & (US$ Million)
    Figure 15. United States Hemophilia Treatment Market Share by Type (2017-2028)
    Figure 16. Product Picture of Replacement Therapy
    Figure 17. Product Picture of ITI Therapy
    Figure 18. Product Picture of Gene Therapy
    Figure 19. Global Hemophilia Treatment Market Share by Application in 2022 & 2028
    Figure 20. Global Hemophilia Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 21. Global Hemophilia Treatment Market Share by Application (2017-2028)
    Figure 22. United States Hemophilia Treatment Market Share by Application in 2022 & 2028
    Figure 23. United States Hemophilia Treatment Market Size by Application (2017-2028) & (US$ Million)
    Figure 24. United States Hemophilia Treatment Market Share by Application (2017-2028)
    Figure 25. North America Hemophilia Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 26. U.S. Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 27. Canada Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 28. Europe Hemophilia Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 29. Germany Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 30. France Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 31. U.K. Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 32. Italy Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 33. Russia Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 34. Asia-Pacific Hemophilia Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 35. China Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 36. Japan Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 37. South Korea Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 38. India Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 39. Australia Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 40. Taiwan Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 41. Indonesia Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 42. Thailand Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 43. Malaysia Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 44. Philippines Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 45. Latin America Hemophilia Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 46. Mexico Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 47. Brazil Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 48. Argentina Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 49. Middle East & Africa Hemophilia Treatment Market Size Growth Rate 2017-2028 (US$ Million)
    Figure 50. Turkey Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 51. Saudi Arabia Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 52. U.A.E Hemophilia Treatment Market Size Growth Rate (2017-2028) & (US$ Million)
    Figure 53. CSL Behring Revenue Growth Rate in Hemophilia Treatment Business (2017-2022)
    Figure 54. Baxalta Revenue Growth Rate in Hemophilia Treatment Business (2017-2022)
    Figure 55. Pfizer Inc Revenue Growth Rate in Hemophilia Treatment Business (2017-2022)
    Figure 56. BioMarin Revenue Growth Rate in Hemophilia Treatment Business (2017-2022)
    Figure 57. Bayer Healthcare Revenue Growth Rate in Hemophilia Treatment Business (2017-2022)
    Figure 58. Biogen Revenue Growth Rate in Hemophilia Treatment Business (2017-2022)
    Figure 59. Novo Nordisk Revenue Growth Rate in Hemophilia Treatment Business (2017-2022)
    Figure 60. Roche Revenue Growth Rate in Hemophilia Treatment Business (2017-2022)
    Figure 61. Takeda Revenue Growth Rate in Hemophilia Treatment Business (2017-2022)
    Figure 62. Bottom-up and Top-down Approaches for This Report
    Figure 63. Data Triangulation
    Figure 64. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
CSL Behring
Baxalta
Pfizer Inc
BioMarin
Bayer Healthcare
Biogen
Novo Nordisk
Roche
Takeda
Frequently Asked Questions
Hemophilia Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Hemophilia Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Hemophilia Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports

Hopper Cone

Hopper Cone market is segmented by region (country), players, by Type and by Application. Players ... Read More

Food Biotechnology

Food Biotechnology market is segmented by region (country), players, by Type and by Application.  ... Read More